USPTO serial 79251213
BUNGEMAXX
Reviewed by CopyMark Law Group
Reg. 5917307Status 739Registered
- Filing date
- Status date
- Registration date
- Nov 26, 2019
- Examiner
- EINSTEIN, MATTHEW T
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with BUNGEMAXX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Joel D. Leviton
Joel D. Leviton Stinson LLP7700 Forsyth Boulevard, Suite 1100St. Louis, MO 63105United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | [ Chemical additives for use in the manufacture of cosmetics; chemical additives for use in the manufacture of pharmaceuticals; ] chemical additives for use in the manufacture of food; [ antioxidants for the manufacture of cosmetics; vitamins for the manufacture of cosmetics; chemical preparations for use in the manufacture of cosmetics; antioxidants for the manufacture of food supplements; ] proteins for the manufacture of food supplements; [ vitamins for the manufacture of food supplements; ] proteins for the food industry; [ vitamins for the food industry; ] chemical preparations for preserving foodstuffs; [ chemical additives for oils; ] oils for the preservation of food; [ vitamins for use in the manufacture of pharmaceuticals; preserving agents for the pharmaceutical industry; ] raw material, namely, lecithin for use in the manufacture of food products; lecithin for industrial purposes; lecithin for the food industry; chemical additives for the manufacture of food and beverages based on [ ascorbic acid, carbohydrate, tocopherols, ] lecithin [ , vitamin E, sterols and ester sterols, glycerin, proteins, tocotrienols, squalene, carotenoids; antioxidants for the manufacture of pharmaceutical products ] | ACTIVE | — |
| 005 | [ Medicinal preparations for management of gallstones, management of liver disorders, management of neurological disorders, improving memory, improving attention, improving cognitive decline, modulation of mood and stress, management of heart-related conditions, management of cholesterol levels, management of atherosclerosis and heart disease; pharmaceutical preparations for management of gallstones, management of liver disorders, management of neurological disorders, improving memory, improving attention, improving cognitive decline, modulation of mood and stress, management of heart-related conditions, management of cholesterol levels, management of atherosclerosis and heart disease; ] nutraceutical preparations for therapeutic or medical use [ for management of gallstones, management of liver disorders, management of neurological disorders, improving memory, improving attention, improving cognitive decline, modulation of mood and stress, management of heart-related conditions, management of cholesterol levels, management of atherosclerosis and heart disease; ] dietetic foods for medical use; [ antioxidants for medical use for management of gallstones, management of liver disorders, management of neurological disorders, improving memory, improving attention, improving cognitive decline, modulation of mood and stress, management of heart-related conditions, management of cholesterol levels, management of atherosclerosis and heart disease; ] food supplements; [ antioxidants used as food supplements; adjuvants for medical use; ] lecithin for pharmaceutical use [ for management of gallstones, management of liver disorders, management of neurological disorders, improving memory, improving attention, improving cognitive decline, modulation of mood and stress, management of heart-related conditions, management of cholesterol levels, management of atherosclerosis and heart disease; vitamin preparations; preparations for medical use containing vitamins, trace elements, fatty acids, amino acids, enzymes and coenzymes, or plant extracts for medicinal use for management of gallstones, management of liver disorders, management of neurological disorders, improving memory, improving attention, improving cognitive decline, modulation of mood and stress, management of heart-related conditions, management of cholesterol levels, management of atherosclerosis and heart disease; food supplements of proteins, carbohydrates, ores, lipids, sterol or other nutrients including ascorbic acid, tocopherols, ] lecithin, [ vitamin E, sterols and ester sterols, glycerin, ] proteins [ , tocotrienols, squalene, carotenoids ] | ACTIVE | — |
| 029 | Processed food preparations and dishes made with meat, [ fish, poultry, game, meat extracts, preserved, frozen, dried and cooked fruits and vegetables, jellies, jams, compotes, eggs, ] milk and milk products, edible oils and fats, and also containing [ natural components, antioxidants, carotenoids or other natural components, ascorbic acid, tocopherols, ] lecithin [ , vitamin E, sterols and ester sterols, glycerin, proteins, tocotrienols, squalene, carotenoids, not for medical use ] ; lecithin for culinary use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BUNGE LIMITED
- Other trademarks owned by BUNGE LIMITED
- Other trademarks owned by BUNGE LIMITED
- Other trademarks owned by BUNGE SA
- Other trademarks owned by BUNGE SA
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 029
- Similar marks named BUNGEMAXX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 8, 2026 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jul 24, 2026 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jul 9, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 7, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 7, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 7, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 8, 2025 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Dec 8, 2025 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Dec 1, 2025 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Nov 24, 2025 | PR75 | POST REGISTRATION ACTION MAILED - SEC. 71 & 15 | — |
| Nov 17, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jul 17, 2025 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Nov 26, 2024 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Aug 7, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 7, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 7, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 7, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Aug 7, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Apr 5, 2024 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| May 4, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 4, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 4, 2023 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| May 4, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 4, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 4, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Nov 27, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 27, 2020 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Apr 3, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 18, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 18, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 26, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 26, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 10, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 10, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 21, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 8, 2019 | ALIE | ASSIGNED TO LIE | — |
| Jul 29, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 29, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 29, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 29, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 29, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 26, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 25, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 25, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 29, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 15, 2019 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Mar 9, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 9, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 1, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 28, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 25, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 15, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 11, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 7, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |